Clinuvel Pharmaceuticals Limited (CLVLY) Shareholder/Analyst Call Transcript

ConversationJeffrey Rosenfeld Good morning, ladies and gentlemen. My name is Professor Jeffrey Rosenfeld, and I have the privilege of being the Chair of CLINUVEL Pharmaceuticals Limited. As Chair of today's meeting, it is my pleasure to welcome you to CLINUVEL's 2025 AGM. I note that we have complied with the relevant requirements for convening this meeting and that a quorum is present. As the time is now 10:00 a.m. in Melbourne, just after, I formally declare the meeting open. Before the formal business ...